Promoting Competition
and Investment in the
U.S. Life Sciences Ecosystem

The U.S. life sciences ecosystem depends on mergers and acquisitions (M&A) to bring together the resources, investment and expertise needed to develop and deliver new treatments and cures for patients.

DRIVING THE INNOVATION ECOSYSTEM
M&A fuels innovation across a diverse and dynamic life sciences ecosystem.
LEVERAGING EFFICIENCY AND EXPERTISE
M&A drives efficiency and expertise across the life sciences industry, expediting the process of bringing new treatments and cures to market.
PRESERVING AMERICAN LEADERSHIP
M&A is a core component of the unique and world-class American life sciences ecosystem.

U.S. biopharmaceutical companies with establishments in every state

invested in R&D by top 15 biopharmaceutical companies

of biopharmaceutical companies operate without a profit

PARTNERS

See All Partners

ABOUT US

PULSE is dedicated to raising awareness about the vital role of mergers and acquisitions (M&A) as well as other collaborations to bring together the resources, investment and expertise needed to develop and deliver new treatments and cures for patients. Our members represent frontline researchers, employees and leaders of life sciences companies of all sizes that support a diverse, vibrant life sciences ecosystem at the national level and in local communities. PULSE will help advance a national dialogue focused on fostering innovation across the life sciences while supporting a competitive U.S. market that delivers next generation treatments and cures
for patients.

Learn More

LATEST NEWS

New PULSE Resource: Life Sciences Innovations Advanced by M&A

Mar 25, 2025

For decades, mergers and acquisitions (M&A) have fueled the development and delivery of breakthrough treatments for complex diseases with a high unmet need. A new resource from the Partnership for the U.S. Life Science Ecosystem (PULSE) spotlights this unique and...

read more
See All News